Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1995
06/06/1995US5422250 Including in the culture medium a sulfated polysaccharide
06/06/1995US5422249 Process for the manufacture of thrombin inhibitors
06/06/1995US5422125 Administering to human or animal patients magnesium vanadate
06/06/1995US5422105 Use of recombinant colony stimulating factor 1
06/06/1995US5422104 TNF-muteins
06/06/1995US5422103 Wound healing agents for burns, bed sores; blended with dextran
06/06/1995US5422090 Human PAI-2
06/06/1995US5421839 Fermentatiion of aspergillus giganteus
06/06/1995CA1335802C O-glycosylated igf-1
06/06/1995CA1335800C Synovial phospholipases
06/06/1995CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
06/06/1995CA1335789C Fatty acid compositions
06/06/1995CA1335788C Protein absorption enhancing agents
06/01/1995WO1995014930A1 Kinase receptor activation assay
06/01/1995WO1995014787A1 Peptide inhibitors of selecting binding
06/01/1995WO1995014785A1 Composition for the in vivo production of therapeutic products
06/01/1995WO1995014780A2 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
06/01/1995WO1995014779A1 Mutated hig-e fragments and derivative thereof
06/01/1995WO1995014778A2 Dna sequence coding for a bmp receptor
06/01/1995WO1995014777A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
06/01/1995WO1995014776A1 PROTEIN TYROSINE KINASES NAMED Rse
06/01/1995WO1995014773A1 New transcription factor mutants and use thereof
06/01/1995WO1995014714A1 Novel integrin-binding peptides
06/01/1995WO1995014713A2 Abundant extracellular products and methods for their production and use
06/01/1995WO1995014711A1 Cell adhesion molecules and detecting adherence
06/01/1995WO1995014707A1 N-2 substituted purines
06/01/1995WO1995014706A1 Pna-dna-pna chimeric macromolecules
06/01/1995WO1995014682A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
06/01/1995WO1995014666A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
06/01/1995WO1995014493A1 Three-step pretargeting methods and compounds
06/01/1995WO1995014490A1 Use of lithium compounds in the treatment of cardiac insufficiency
06/01/1995WO1995014489A1 Composition comprising compounds for use as therapeutical agent
06/01/1995WO1995014488A1 Compositions and methods for the treatment of dry eyes and other ocular disorders
06/01/1995WO1995014487A1 Treatment of viral disease with cd40l peptide
06/01/1995WO1995014486A1 Medicinal activity of aspartame
06/01/1995WO1995014471A1 Antiarrhythmic benzodiazepines
06/01/1995WO1995014465A2 Methods for amelioration of immunodeficiency virus induced neurodegeneration by covering nitric oxide or superoxide concentration
06/01/1995WO1995014436A1 A retrograde high frequency tissue splitter
06/01/1995WO1995006732A3 Bacterial exported proteins and acellular vaccines based thereon
06/01/1995DE4340798A1 New thrombin inhibitory proteins from saliva of blood sucking insects
06/01/1995CA2177075A1 Medicinal activity of aspartame
06/01/1995CA2177074A1 P53-binding polypeptides and polynucleotides encoding same
06/01/1995CA2177070A1 Novel integrin-binding peptides
06/01/1995CA2177037A1 Three-step pretargeting methods and compounds
06/01/1995CA2176140A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
06/01/1995CA2176015A1 Antiarrhythmic benzodiazepines
06/01/1995CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
05/1995
05/31/1995EP0655501A1 HIV-2 virus variants
05/31/1995EP0655500A1 Allergenic polypeptide from Japanese cedar pollen and dna encoding it
05/31/1995EP0655463A1 Cyclic hexapeptides having endothelin antagonistic activity
05/31/1995EP0655462A1 Linear adhesion inhibitors
05/31/1995EP0655461A1 Cyclic amino acid derivatives having ACE and NEP inhibiting activity
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655252A1 Agent for suppressing the motor activity of gastrointestinal tracts
05/31/1995EP0655251A1 Pharmaceutical composition for preventing or treating
05/31/1995EP0655245A2 Compositions and their use for retarding the aging process
05/31/1995EP0655244A1 Amino acid composition for the treatment of infections
05/31/1995EP0655237A1 Medicinal aerosol formulation
05/31/1995EP0655089A1 Effects of actin filaments on fibrin clot structure and lysis
05/31/1995EP0655072A1 Equine herpesvirus glycoproteins
05/31/1995EP0654968A1 Anti-microbial composition
05/31/1995EP0557270B1 Cationized antibodies for delivery through the blood-brain barrier
05/31/1995EP0553281B1 Preparation and characterization of liposomal formulations of tumor necrosis factor
05/31/1995EP0375724B1 Biologically active bactericidal/permeability-increasing protein fragments
05/31/1995EP0329778B1 Molecular decoyants and methods of use thereof
05/31/1995CN1102993A Method for making Chinese medicine herbs preparation by polyenzyme system
05/31/1995CA2137025A1 Liquid preparations containing cyclosporin and process for preparing same
05/31/1995CA2110213A1 Inhibition of dna metase for therapy
05/30/1995US5420347 Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine
05/30/1995US5420297 Peptides having substance P antagonistic activity
05/30/1995US5420264 Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof
05/30/1995US5420263 Amplification of human MDM2 gene in human tumors
05/30/1995US5420252 For treatment of thrombotic disorders
05/30/1995US5420251 Anti-idiotype antibodies specific for the parotope of antibodies which bind to IgE-bearing B cells but not basophils
05/30/1995US5420249 Incubation of proteins and separation
05/30/1995US5420247 Genetic engineering and expression vectors
05/30/1995US5420246 Having a predetermined amount of each peptide
05/30/1995US5420245 Tetrapeptide-based inhibitors of farnesyl transferase
05/30/1995US5420243 Transforming growth factor
05/30/1995US5420242 Production of human parathyroid hormone from microorganisms
05/30/1995US5420228 Fluorescent-labelled bleomycin analogues
05/30/1995US5420113 [Leu13]motilin, DNAs coding for same and methods for producing same
05/30/1995US5420112 Prevention and treatment of peripheral neuropathy
05/30/1995US5420111 Somatomedins, fetal growth promoters
05/30/1995US5420110 Compositions and methods for inhibiting elastase
05/30/1995US5420109 Cytokine restraining agents
05/30/1995US5420108 Method of controlling diabetes mellitus
05/30/1995US5420107 Method and composition for energy source supplementation during exercise and recovery
05/30/1995US5420105 Polymeric carriers for non-covalent drug conjugation
05/30/1995US5420019 Stable bactericidal/permeability-increasing protein muteins
05/30/1995US5419906 Acidic, low temperature incubation
05/30/1995US5419904 Human B-lymphoblastoid cell line secreting anti-ganglioside antibody
05/30/1995US5419901 Blood pressure increase
05/30/1995US5419900 Autoimmune disease
05/30/1995US5419899 Purified, reduced recombinant interleukin-2 compositions
05/30/1995US5419315 Intrapulmonary delivery of hormones
05/30/1995CA2050303C Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions
05/30/1995CA1335722C Polyethylene glycol derivatives, modified peptides and production thereof
05/30/1995CA1335717C Human granulocyte-macrophage colony stimulating factor and muteins thereof
05/30/1995CA1335716C Methods for increasing extracellular adenosine and for stabilizing mast cells
1 ... 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 ... 3163